Towards Healthcare
Western Blotting Market to Grow at 6.05% CAGR by 2034

Western Blotting Market Opportunities and 48% North America Dominance

Based on market forecasts, the western blotting sector will expand from USD 2.01 billion in 2024 to USD 3.6 billion by 2034, experiencing a CAGR of 6.05%. The increasing prevalence of chronic disorders and technological advancements drive the market. North America dominated the global market owing to the presence of key players and increasing research investments.

Content

  • Last Updated: 03 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The western blotting market is poised for steady growth, projected to reach USD 3.6 billion by 2034 at a CAGR of 6.05%

Asia-Pacific presents the fastest growth opportunities due to increased government support, biotech startups, and a rising burden of infectious diseases

Artificial Intelligence and microfluidics are major disruptors. AI enhances pattern recognition and image analysis, reducing manual errors

AI significantly boosts reproducibility, speed, and accuracy in Western Blotting by automating image analysis and reducing human error.

Major players include Bio-Rad Laboratories, Thermo Fisher Scientific, GE Healthcare, and Proteintech Group.

Stringent regulations, especially in regions like Europe and Japan, ensure the safety and accuracy of diagnostic applications.

The primary restraint is the lack of skilled professionals, particularly in developing regions.
Any Questions